NasVax, an Israeli company based in Ness-Ziona, has developed an oral treatment for people suffering from Nonalcoholic steatohepatitis (NASH) commonly known as “fatty liver disease” which affects up to 15 million US citizens. It is undergoing trials and also conversion into a pill.
http://unitedwithisrael.org/nasvax/